Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy

Nature Medicine

Volumn 3, Issue 10, 1997, Pages 1102-1109

  Withers Ward, Elizabeth S ^a   Amado, Rafael G ^a   Koka, Prasad S ^a   Jamieson, Beth D ^a   Kaplan, Andrew H ^a   Chen, Irvin S Y ^a   Zack, Jerome A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 77003; ANTIRETROVIRUS AGENT; DIDANOSINE; PROTEINASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPLANT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTOPOIESIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; THYMUS; THYMUS FUNCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DIDANOSINE; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; LYMPHOCYTE DEPLETION; METHYLUREA COMPOUNDS; MICE; MICE, SCID; POLYMERASE CHAIN REACTION; PROVIRUSES; PYRIDINES; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION, HETEROLOGOUS; ZIDOVUDINE;

EID: 0030842948     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1097-1102     Document Type: Article

References (30)

1. Ho, D. D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126 (1995).
2. Wei, X. et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122 (1995).
3. Papiernik, M. et al. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89, 297-301 (1992).
4. Schuurman, H.J. et al. The thymus in acquired immunodeficiency syndrome: Comparison with other types of immunodeficiency diseases and presence of components in human immunodeficiency virus type 1. Am. J. Pathol. 134, 1329-1338 (1989).
5. Grody, W., Fligiel, S. & Naeim, F. Thymus involution in the acquired immunodeficiency syndrome. Am. J. Clin. Pathol. 84, 85-95 (1985).
6. Joshi, V.V. et al. Thymus biopsy in children with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 110:837-842 (1986).
7. Rosenzweig, M., Clark, D.P. & Gaulton, G.N. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7, 1601-1605 (1993).
8. McCune, J.M. et al. The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639 (1988).
9. Namikawa, R., Weilbaecher, K.N., Kaneshima, H., Yee, E.J. & McCune, J.M. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172, 1055-1063 (1990).
10. Aldrovandi, G.M. et al. HIV-1 infection of the SCID-hu mouse: An animal model for virus pathogenesis. Nature 363, 732-736 (1993).
11. Bonyhadi, M.L. et al. HIV induces thymus depletion in vivo. Nature 363, 728-736 (1993).
12. Stanley, S.K. et al. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178, 1151-1163 (1993).
13. Kollmann, T.R. et al. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J. Exp. Med. 179, 513-522 (1994).
14. Akkina, R.K., Rosenblatt, J.D., Campbell, A.G., Chen, I.S.Y. & Zack, J.A. Modeling human stem cell gene therapy in the SCID-hu mouse. Blood 84, 1393-1398 (1994).
15. An, D.S. et al. High-efficiency gene transduction of human T-cell progenitors. J. Virol. 71, 1397-1404 (1997).
16. Jamieson, B.D. et al. Requirement of HIV-1 nef for in vivo replication and pathogenesis. J. Virol. 68, 3478-3485 (1994).
17. Jamieson, B.D., Pang, S., Aldrovandi, C. M., Zha, J. & Zack, J.A. In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J. Virol. 69, 6259-6264 (1995).
18. Aldrovandi, G.M. & Zack, J.A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70, 1505-1511 (1996).
19. + cell depletion in HIV-1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J. Virol. (in the press).
20. Kaneshima, H. et al. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse. Proc. Natl. Acad. Sci. USA 88, 4523-4527 (1991).
21. McCune, J.M., Namikawa, R., Shih, C.-C., Rabin, L. & Kaneshima, H. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 247, 564-566 (1990).
22. Zack, J.A. et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222 (1990).
23. Kaplan, A.H. et al. Partial inhibition of human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67, 4050-4055 (1993).
24. Jaskolski, M. et al. Structure at 2.5-Å resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. Biochemistry 30, 1600-1609 (1991).
25. Lech, W.J. et al. In vivo sequence diversity of the protease of the human immunodeficiency virus type 1: Presence of protease inhibitor resistant variants in untreated subjects. J. Virol. 70, 2038-2045 (1996).
26. Kaplan, A.H. et al. Selection of multiple HIV-1 variants with decreased sensitivity to an inhibitor of the viral protease. Proc. Natl. Acad. Sci. USA 91, 5597-5601 (1994).
27. Ho, D.D. et al. Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor. J. Virol. 68, 2016-2020 (1994).
28. + T-cell homeostasis and function in advanced HIV disease. Science 27, 112-116 (1997).
29. Sato, A. et al. A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice. Antiviral Res. 27, 151-163 (1995).
30. Vacca, J.P. et al. L-735,524: An orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc. Natl. Acad. Sci. USA 91, 4096-4100 (1994).